STOCK TITAN

Genix Pharmaceuticals Corp - GENPF STOCK NEWS

Welcome to our dedicated news page for Genix Pharmaceuticals (Ticker: GENPF), a resource for investors and traders seeking the latest updates and insights on Genix Pharmaceuticals.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Genix Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Genix Pharmaceuticals's position in the market.

Rhea-AI Summary
Genix Pharmaceuticals Corporation (GENX) has received approval from the TSX Venture Exchange to amend the exercise price and warrant accelerator terms, as well as extend the expiry dates of previously issued warrants. The exercise price of the warrants will be reduced from $0.30 to $0.15 per warrant share, and the accelerator repricing will be adjusted from $0.50 to $0.25 per share. Additionally, 2,101,612 warrants will be extended to July 24, 2025, and 1,253,333 warrants will be extended to August 13, 2025. The company acknowledges clerical errors in previous press releases and apologizes for any inconvenience caused.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Genix Pharmaceuticals Corporation (GENPF) has applied to the TSX Venture Exchange to amend the exercise price, warrant accelerator terms, and extend the expiry date of previously issued warrants. The proposed amendments include reducing the exercise price of the warrants, subjecting them to an accelerator repricing, and extending the expiry dates of certain warrants. The amendments are subject to the consent of all warrant holders and the approval of the TSX Venture Exchange.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Genix Pharmaceuticals Corp

OTC:GENPF

GENPF Rankings

GENPF Stock Data

2.61M
33.00M
45.12%
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Manufacturing
Link
Canada
Vancouver